Array BioPharma (ARRY) PT Raised to $35 at Piper Jaffray
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $5.17 -0.39%
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 14 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Jaffray analyst Edward Tenthoff raised the price target on Array BioPharma (NASDAQ: ARRY) to $35.00 (from $28.00) while maintaining a Overweight rating.
- BEACON Interim Analysis Hits, sNDA Filing in 2H:19
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,278 at TD Cowen
- Asia Vital Components Co Ltd (3017:TT) PT Raised to NT$4,250 at Macquarie
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Piper Jaffray, Edward TenthoffSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
